Advanced Granulation and Formulation Strategies for Histamine H2 Receptor Antagonists in Peptic Ulcer Disease Management

Authors

  • K Venkata Gopaiah
  • Ramya Teja Medarametla
  • J N Suresh Kumar
  • Chilakala Sahithi
  • Dhanankula Eswari Sai Prasanna
  • Gali Sathwik
  • Gongati Sravani
  • Kalluri Murali

DOI:

https://doi.org/10.63682/jns.v14i10S.6812

Keywords:

HPMC K4M, HPMC K15M, HPMC K100M, PUD

Abstract

Present work seeks to formulate floating tablets of famotidine Hydrochloride employing HPMC K4M, HPMC K15M and HPMC K100M polymers. The bulk density of the floating drug delivery systems is lower than the gastric fluid density and therefore has the potential to be suspended in the gastric cavity for long durations of time although the rate of gastric emptying is unaffected. Famotidine is classified as a histamine H2 receptor antagonist and it is on the World Health Organization's Model List of Essential Medicines used for the treatment of peptic ulcer disease (PUD) and gastro oesophageal reflux disease (GERD). Due to its short half-life, short gastric resorption time and multiple dosages any formulator may suggest famotidine as an exceptional drug for formulating floating drug delivery systems. Famotidine floating tablets were developed by using HPMC K4M, HPMC K15M and HPMC K100M by melt granulation technique. The floating tablets were evaluated for following parameters: weight variation, hardness, friability, thickness, drug content, in-vitro buoyancy, drug polymer compatibility (IR study), and in-vitro dissolution studies of tablets. The micromeritic properties were observed to be satisfactory, the tablets were able to remain buoyant in the dissolution medium and the in vitro release studies indicated a good and rapid release nature of the tablets. Formulation F4 of HPMC K100M exhibited good in-vitro buoyancy lag time & floating time in which in lowering the density of all the formulations and in-vitro dissolution showed 96.78% drug release in 12 hrs

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Norman J, Madurawe RD, Moore CMV, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev. 2017 Jan 1;108:39–50. doi: 10.1016/j.addr.2016.03.001.

Gopaiah K. V., Kumar J. N. S., Teja M. R., Lokesh T., Sruthi D. S., Roja M., Rushitha N., Vahedunnisa S. K., "Development and Assessment of Hydroxypropyl Methylcellulose-Based Floating Tablets for Ciprofloxacin HCL Using Direct Compression Technique," Journal of Pharmaceutical Research International, vol. 36, no. 3, pp. 47–62, 2024.

S. Budavari, M. O’Neil, A. Smith, P. Heckelman, and J. Obenchain, The Merck index : an encyclopedia of chemicals, drugs, and biologicals, 12th ed. Whitehouse Station NJ: Merck, 1996.

Z. Fedorowicz, E. J. van Zuuren, and N. Hu, “Histamine H2-receptor antagonists for urticaria,” Cochrane Database of Systematic Reviews, vol. 2012, no. 3, Mar. 2012, doi: 10.1002/14651858.CD008596.pub2.

Gopaiah K. V., Gowtham M., Pracheta K., "Development and assessment of Rapid-Dissolving Enalapril Malate Tablets Utilizing Co-Processed Super Disintegrates," International Journal of Innovation Scientific Research and Review, vol. 6, no. 10, pp. 7181–7185, 2024.

Formlabs. Stereolithography (SLA) 3D Printing Guide. Available from: https://formlabs.com/blog/ultimateguide-to-stereolithography-sla-3d-printing/ [Accessed Mar. 15, 2022].

Gopaiah K. V., Ramya Teja M., Kumar J. N. S., Kilari N., Nelapati V. S., Vellaturi P., Irfan J. S., Manjula P., "Innovations and Techniques in Oral Controlled Release Systems: A Comprehensive Review of Tablet Characterization Methods," Journal of Current Pharma Research, vol. 20, no. 9, pp. 16–24, 2024.

Nano-DI. The 3D Inkjet Printing Process Explained. Available from: https://www.nano-di.com/blog/2019-the-3d-inkjet-printing-process-explained [Accessed Mar. 15, 2022].

Gopaiah K. V., Gowtham M., Pracheta K., Ramya Teja M., "Synergistic Elegance: Harnessing Liposomes as Advanced Cosmetic Drug Delivery Systems with Phospholipids and Phenolic Components," Pharmaceutical Sciences & Analytical Research Journal, vol. 6, no. 3, pp. 1–8, 2024.

Gopaiah K. V., Medarametala R. T., Kumar J. N. S., Sahithi C., Prasanna D. E., Sathwik G., Sravani G., Murali K., "Comprehensive analysis of Nizatidine: Pharmacodynamics and pharmacokinetics in anti-ulcer treatment," World Journal of Advanced Research and Reviews, vol. 23, no. 3, pp. 2260–2266, 2024.

Maniruzzaman M, et al. A Review of Hot-Melt Extrusion: Process Technology to Pharmaceutical Products. ISRN Pharmaceutics. 2012;2012:436763. doi: 10.5402/2012/436763.

Patil H, Tiwari RV, Repka MA. Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation. AAPS PharmSciTech. 2016 Feb;17(1):20–42. doi: 10.1208/s12249-015-0360-7.

Gopaiah K. V., Kolli P., Mandadapu G., "Solid Lipid Nanoparticles of Naftopidil: Formulation Design & In Vitro Evaluation for Improved Oral Absorption," Pharmaceutical Sciences & Analytical Research Journal, vol. 6, no. 2, pp. 180061, 2024.

Lepowsky E, Tasoglu S. 3D printing for drug manufacturing: A perspective on the future of pharmaceuticals. Int J Bioprinting. 2018;4(1):119. doi: 10.18063/IJB.v4i1.119.

Mohamed OA, Masood SH, Bhowmik JL. Optimization of fused deposition modeling process parameters: a review of current research and future prospects. Adv Manuf. 2015 Mar;3(1):42–53. doi: 10.1007/s40436-014-0097-7.

Gopaiah K. V., Mandadapu G., Kolli P., "Impact of Metformin on Cardiac Autonomic Function in Recently Diagnosed Type-2 Diabetic Patients at a Specialized Medical Center," TIJER - International Research Journal, vol. 11, no. 5, pp. b331–b336, 2024.

Medarametla R. T., Gopaiah K. V., Kumar J. N. S., Sai A. K., Chari G. M., Kiran A. K., Naik B. K., Rani K. S., "Clinical Investigation of Valsartan Sustained-Release Matrix Tablets: Formulation Design and Performance Evaluation," Journal of Pharmaceutical Research International, vol. 36, no. 2, pp. 39–54, 2024.

Mandadapu G., Kolli P., Gopaiah K. V., "Formulation of fenofibrate capsules by dropping method using PEG 6000 and PEG 4000 to enhance solubility," World Journal of Biology Pharmacy and Health Sciences, vol. 19, no. 1, pp. 95–102, 2024.

Chukka A. K., Gopaiah V., Chowdary D., Irfan J. S., "A review of synthesis, biological activity, & docking studies of anti-tubercular agents," Journal of Innovations in Applied Pharmaceutical Science, pp. 45–50, Dec. 2023.

Medarametla R., Gopaiah V., Ch G., Neelima L., Reddy A., Sudheer B., "Formulation and evaluation of tenoxicam ethosomes as a novel drug carrier," UPI Journal of Pharmaceutical, Medical and Health Sciences, pp. 12–18, Nov. 2023.

Medarametla R. T., Gopaiah V., "A comprehensive study on the review of virosomes as a novel drug delivery system," UPI Journal of Pharmaceutical, Medical and Health Sciences, vol. 1, no. 6, pp. 1–6, Oct. 2023.

Gopaiah V., Brahmam G., Harika R., Pujitha V., "Formulation & Evaluation of Cefuroxime Oral suspension for Pediatrics," International Journal of Current Innovations in Advanced Research, pp. 60–67, Apr. 2023.

Gopaiah K. V., Mandadapu G., Kolli P., "A Study on Method Development for Detection of Different Viral Antibodies and Virus by Using RT-PCR Method," World Journal of Pharmaceutical Research, vol. 12, no. 4, pp. 316–333, Mar. 2023.

Nanodimension. The 3D printing process explained. Available from: https://www.nano-di.com/blog/2019-the-3d-inkjet-printing-process-explained [Accessed Feb. 22, 2022].

Gopaiah K. V., Mandadapu G., Kolli P., Bhavana T., "Diagnosing Feline & Canine Disease by RT-PCR Screens," International Journal of Research and Analytical Review, vol. 10, no. 1, pp. 590–603, Feb. 2023.

Gopaiah K. V., Mandadapu G., Kolli P., Patibandal S., "A Clinical Study on Chronic Obstructive Pulmonary Disorder," Journal of Emerging Technologies and Innovative Research, vol. 10, no. 1, pp. b393–b453, Oct. 2023.

Mandadapu G., Kolli P., Gopaiah K. V., "Formulation and Evaluation of Econazole nitrate Nanoemulsion for Fungal Topical Use," Journal of Emerging Technologies and Innovative Research, 2024.

Shrivastava B., "Topical combination delivery of benzoyl peroxide and adapalene niosomal gel for acne treatment," Asian Journal of Pharmaceutics, vol. 13, no. 4, Nov. 2019.

Gopaiah M. K., "Design, formulation, and evaluation of sustained release tablets for antihyperlipidemic agent," Asian Journal of Pharmaceutics, vol. 12, no. 4, Nov. 2018.

Melocchi, F. Parietti, A. Maroni, A. Foppoli, A. Gazzaniga, and L. Zema, “Hot- melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling,” Int J Pharm, vol. 509, no. 1–2, pp. 255–263, Jul. 2016, doi: 10.1016/J.IJPHARM.2016.05.036.

Awad, S. J. Trenfield, S. Gaisford, and A. W. Basit, “3D printed medicines: A new branch of digital healthcare,” Int J Pharm, vol. 548, no. 1, pp. 586–596, Sep. 2018, doi: 10.1016/J.IJPHARM.2018.07.024.

Mandadapu G., Kolli P., Gopaiah K. V., "Formulation and Evaluation of Econazole nitrate Nanoemulsion for Fungal Topical Use," World Journal of Pharmaceutical Research, 2024.

Gopaiah K. V., Kumar J. N. S., Teja M. R., "Development and Assessment of Hydroxypropyl Methylcellulose-Based Floating Tablets for Ciprofloxacin HCL Using Direct Compression Technique," Journal of Pharmaceutical Research International, vol. 36, no. 3, pp. 47–62, 2024.

Mandadapu G., Kolli P., Gopaiah K. V., Bhavana T., "Diagnosing Feline & Canine Disease by RT-PCR Screens," International Journal of Research and Analytical Review, vol. 10, no. 1, pp. 590–603, Feb. 2023.

Medarametla R. T., Gopaiah K. V., Kumar J. N. S., "Clinical Investigation of Valsartan Sustained-Release Matrix Tablets: Formulation Design and Performance Evaluation," Journal of Pharmaceutical Research International, vol. 36, no. 2, pp. 39–54, Mar. 2024.

Gopaiah K. V., Medarametala R. T., Kumar J. S., "Comprehensive analysis of nizatidine: Pharmacodynamics and pharmacokinetics in anti-ulcer treatment," World Journal of Advanced Research and Reviews, vol. 23, no. 3, pp. 2260–2266, 2024.

Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D Printing Pharmaceuticals: Drug Development to Frontline Care. Trends Pharmacol Sci. 2018 May;39(5):440–51. doi: 10.1016/j.tips.2018.02.006.

Melocchi, F. Parietti, A. Maroni, A. Foppoli, A. Gazzaniga, and L. Zema, “Hot- melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling,” Int J Pharm, vol. 509, no. 1–2, pp. 255–263, Jul. 2016, doi: 10.1016/J.IJPHARM.2016.05.036.

Awad, S. J. Trenfield, S. Gaisford, and A. W. Basit, “3D printed medicines: A new branch of digital healthcare,” Int J Pharm, vol. 548, no. 1, pp. 586–596, Sep. 2018, doi: 10.1016/J.IJPHARM.2018.07.024.

P. O. Talke and D. R. Solanki, “Dose-response study of oral famotidine for reduction of gastric acidity and volume in outpatients and inpatients,” Anesth Analg, vol. 77, no. 6, pp. 1143–1148, 1993, doi: 10.1213/00000539-199312000- 00011.

Downloads

Published

2025-05-30

How to Cite

1.
Gopaiah KV, Medarametla RT, Kumar JNS, Sahithi C, Sai Prasanna DE, Sathwik G, Sravani G, Murali K. Advanced Granulation and Formulation Strategies for Histamine H2 Receptor Antagonists in Peptic Ulcer Disease Management. J Neonatal Surg [Internet]. 2025May30 [cited 2025Oct.1];14(10S):1000-13. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/6812

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.